Lataa...

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

The identification of individuals at risk for Alzheimer's disease (AD) is essential for the timely administration of treatment approaches aimed at slowing the onset or progression of the disease. As amnestic forms of mild cognitive impairment (aMCI) may represent preclinical AD, the search for...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Counts, Scott E., Mufson, Elliott J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3035316/
https://ncbi.nlm.nih.gov/pubmed/21311725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10134-010-0004-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!